Voyager Therapeutics, Inc.

NasdaqGS:VYGR 주식 보고서

시가총액: US$321.2m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Voyager Therapeutics 미래 성장

Future 기준 확인 0/6

Voyager Therapeutics 의 수익과 수익은 각각 연간 11% 및 24.1% 감소할 것으로 예상됩니다. EPS는 연간 13.8% 만큼 쇠퇴할 것으로 예상됩니다. 자기자본이익률은 3년 후 -27% 로 예상됩니다.

주요 정보

-24.1%

수익 성장률

-13.8%

EPS 성장률

Biotechs 수익 성장28.4%
매출 성장률-11.0%
향후 자기자본 수익률-27.0%
애널리스트 커버리지

Good

마지막 업데이트26 Sep 2024

최근 미래 성장 업데이트

Earnings Beat: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Aug 09
Earnings Beat: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Recent updates

Voyager Therapeutics: CNS Player In Early Stages Of A Turnaround

Aug 26

Earnings Beat: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Aug 09
Earnings Beat: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Lacklustre Performance Is Driving Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Low P/S

Aug 08
Lacklustre Performance Is Driving Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Low P/S

Voyager: Alzheimer's Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis

Jun 05

There's No Escaping Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Muted Revenues Despite A 28% Share Price Rise

Mar 15
There's No Escaping Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Muted Revenues Despite A 28% Share Price Rise

Voyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easier

Mar 08

What Does The Future Hold For Voyager Therapeutics, Inc. (NASDAQ:VYGR)? These Analysts Have Been Cutting Their Estimates

Mar 04
What Does The Future Hold For Voyager Therapeutics, Inc. (NASDAQ:VYGR)? These Analysts Have Been Cutting Their Estimates

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Surges 45% Yet Its Low P/S Is No Reason For Excitement

Jan 04
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Surges 45% Yet Its Low P/S Is No Reason For Excitement

Voyager stock rises as Pfizer opts to use AAV capsid for neurologic disease target

Oct 04

Voyager Therapeutics hires new finance chief

Sep 07

Voyager Therapeutics GAAP EPS of -$0.50 misses by $0.02

Aug 04

Looking Back In On Voyager Therapeutics

Jun 08

Need To Know: Analysts Just Made A Substantial Cut To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Estimates

May 12
Need To Know: Analysts Just Made A Substantial Cut To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Estimates

Voyager Does A Reboot After First Generation Failures

Mar 25

Companies Like Voyager Therapeutics (NASDAQ:VYGR) Could Be Quite Risky

Feb 07
Companies Like Voyager Therapeutics (NASDAQ:VYGR) Could Be Quite Risky

Voyager Therapeutics: Another Year, Another Deal

Nov 21

수익 및 매출 성장 예측

NasdaqGS:VYGR - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/202654-125-90-836
12/31/202556-119-117-1119
12/31/202469-80-30-259
6/30/20241449-22-18N/A
3/31/2024119-3813N/A
12/31/20232501327578N/A
9/30/2023158528689N/A
6/30/2023195969194N/A
3/31/2023191997477N/A
12/31/202241-46-15-13N/A
9/30/202271-17911N/A
6/30/202231-6046N/A
3/31/202232-7112N/A
12/31/202137-71-55-54N/A
9/30/202116-93-92-87N/A
6/30/202113218-100-91N/A
3/31/202116039-100-89N/A
12/31/202017137-109-97N/A
9/30/202019740-110-98N/A
6/30/2020100-61-103-95N/A
3/31/2020117-41-113-105N/A
12/31/2019104-444149N/A
9/30/201974-544348N/A
6/30/201955-594752N/A
3/31/201912-965761N/A
12/31/20188-88-20-16N/A
9/30/201812-78-10-6N/A
6/30/201811-81-8-5N/A
3/31/201810-74N/A2N/A
12/31/201710-71N/A-61N/A
9/30/20176-74N/A-60N/A
6/30/20178-59N/A-54N/A
3/31/201711-50N/A-47N/A
12/31/201614-40N/A-42N/A
9/30/201617-34N/A-39N/A
6/30/201618-32N/A-36N/A
3/31/201620-30N/A-33N/A
12/31/201517-38N/A41N/A
9/30/201512-35N/A46N/A
6/30/20157-32N/A50N/A
3/31/20153-30N/A55N/A
12/31/2014N/A-18N/A-12N/A

애널리스트 미래 성장 예측

수입 대 저축률: VYGR 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -24.1% ).

수익 vs 시장: VYGR 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -24.1% ).

고성장 수익: VYGR 의 수익은 향후 3년간 감소할 것으로 예상됩니다.

수익 대 시장: VYGR 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -11% ).

고성장 수익: VYGR 의 수익은 향후 3년 동안 감소할 것으로 예상됩니다(연간 -11% ).


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: VYGR (는) 3년 내에 수익성이 없을 것으로 예상됩니다.


성장 기업 발견